Autobio Diagnostics Co., Ltd. (SHA:603658)
China
· Delayed Price · Currency is CNY 35.12
+0.20 (0.57%)
Mar 10, 2026, 11:15 AM CST
Autobio Diagnostics Revenue
Autobio Diagnostics had revenue of 1.07B CNY in the quarter ending September 30, 2025, a decrease of -9.04%. This brings the company's revenue in the last twelve months to 4.22B, down -7.92% year-over-year. In the year 2024, Autobio Diagnostics had annual revenue of 4.47B with 0.62% growth.
Revenue (ttm)
4.22B
Revenue Growth
-7.92%
P/S Ratio
4.73
Revenue / Employee
730.70K
Employees
5,773
Market Cap
19.95B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.47B | 27.55M | 0.62% |
| Dec 31, 2023 | 4.44B | 2.03M | 0.05% |
| Dec 31, 2022 | 4.44B | 675.71M | 17.94% |
| Dec 31, 2021 | 3.77B | 787.79M | 26.45% |
| Dec 31, 2020 | 2.98B | 298.70M | 11.15% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Double Medical Technology | 2.48B |
| MGI Tech | 2.78B |
| MeHow Innovative | 1.63B |
| Shandong Weigao Blood Purification Products | 3.70B |
| Jafron Biomedical | 2.04B |
| Beijing Balance Medical Technology | 630.37M |
| Shanghai MicroPort Endovascular MedTech | 1.35B |
| Lepu Medical Technology (Beijing) | 6.26B |